Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2019 2020 2021 2022 2023 2024 2025
Months
January February March April May June July August September October November December
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

R2,5 million received from FNB Fund for Universal Access and Disability Support
2017-10-18

Description: FNB CUADS Funding Tags: FNB CUADS Funding
Tinotenda Magaya (left at the back), Robert Shoba and
Manus van Rooyen are some of the CUADS students
who will benefit from the money donated by the FNB Fund.
In front are Martie Miranda (left), Head of CUADS, and
Thandeka Rantsi from the FNB Fund.
Photo: Jóhann Thormählen

Funding isn’t only about giving money to provide access to education. There are many factors that contribute to the successful completion of studies, and this is even more applicable to students with disabilities. 

That is why the FNB Fund decided to continue and further its relationship with the Center for Universal Access and Disability Support (CUADS) at the University of the Free State (UFS). The fund recently donated nearly R2.5 million for 2017, 2018, and 2019 to CUADS in order to assist students with tuition fees, study material, accommodation and supportive devices. 

A total of 11 students will benefit from the R 2 497 440. The UFS previously received R200 000 (2014), R238 000 (2015), and R192 500 (2016) from the FNB Fund.

“The FNB Fund would like to take it
a step further and not only provide
access in terms of funding, but also
provide all the support that
students require to be able
to complete their studies.”

Funders should be aware of challenges

“The FNB Fund would like to take it a step further and not only provide access in terms of funding, but also provide all the necessary support that students require to be able to complete their studies,” says Thandeka Rantsi from the FNB Fund.

The fund also partners with disability units from the University of Stellenbosch, the University of the Western Cape, and the University of Cape Town.

Rantsi says funders should be aware of the challenges students with disabilities face in order to provide the right support as their challenges are more extensive.

More flexible funding than others

Martie Miranda, Head of CUADS, says they are very grateful. “In comparison with other funding, this funding provides more flexibility. Because of the gap between government funding and students’ needs, there are always students who fall out of the criteria for the NSFAS bursary. Then the FNB funding comes in very handy.”

According to her, government funding is never enough. She says the FNB funding enables them to address specific needs such as equipment, accommodation etc. as they have more leeway than prescribed NSFAS amounts.

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept